CORRECTING and REPLACING SunLink Health Systems, Inc. Announces Fiscal 2013 Second Quarter and Six M

CORRECTING and REPLACING SunLink Health Systems, Inc. Announces Fiscal 2013 Second Quarter and Six Months Results

ATLANTA--(BUSINESS WIRE)-- Please replace the release dated February 14, 2013 with the following corrected version due to revisions to SunLink Health Systems, Inc.'s boilerplate.

The corrected release reads:


SUNLINK HEALTH SYSTEMS, INC. ANNOUNCES FISCAL 2013 SECOND QUARTER AND SIX MONTHS RESULTS

SunLink Health Systems, Inc. (NYSE MKT: SSY) today announced net earnings for its second fiscal quarter ended December 31, 2012 of $3,935,000, or $0.42 per fully diluted share, compared to a net loss of $935,000, or a loss of $0.10 per fully diluted share, for the quarter ended December 31, 2011. The results for the quarter ended December 31, 2012 include earnings from discontinued operations of $5,330,000 which resulted primarily from an after tax gain of approximately $5,200,000 on the December 31, 2012 sale of substantially all of the assets of its Dexter Hospital, LLC subsidiary. SunLink reported a loss from continuing operations for its second fiscal quarter ended December 31, 2012 of $1,395,000, or $0.15 per fully diluted share, compared to a loss from continuing operations of $1,397,000, or a loss of $0.15 per fully diluted share, for the quarter ended December 31, 2011.

Consolidated net revenues from continuing operations for the quarters ended December 31, 2012 and 2011 were $27,850,000 and $29,025,000, respectively, a decrease of 4.0% in the current year's quarter. The Healthcare Facilities Segment net revenues in the current quarter of $18,610,000 increased $257,000, or 1.4%, compared to $18,353,000 from the prior year. The Specialty Pharmacy Segment revenues of $9,240,000 in the quarter ended December 31, 2012 decreased $1,432,000, or 13.4% from the prior year.

The company had an operating loss from continuing operations for the quarter ended December 31, 2012 of $974,000, compared to an operating loss from continuing operations for the quarter ended December 31, 2011 of $1,059,000. The operating margin increased in the current year's quarter primarily due to the $1,024,000 of Medicaid electronic health records incentive payments compared to $613,000 of Medicaid electronic health records incentive payments in the quarter ended December 31, 2011. Adjusted EBITDA (a non-GAAP measure of the liquidity of the company) at SunLink's Healthcare Facilities Segment in the second fiscal quarter of 2013 was $934,000, which included $1,024,000 of Medicaid electronic health records incentive payments, compared to $902,000 in the same quarter last year which included $613,000 of Medicaid electronic health records incentive payments. Adjusted EBITDA for SunLink's Specialty Pharmacy Segment was $124,000 in the second fiscal quarter compared to Adjusted EBITDA of $285,000 in the comparable quarter a year ago.

For the six months ended December 31, 2012, SunLink reported net earnings of $2,511,000, or $0.27 per fully diluted share, compared to a net loss of $2,490,000, or a loss of $0.27 per share, for the six months ended December 31, 2011. For the six months ended December 31, 2012, SunLink reported a loss from continuing operations of $3,017,000, or a loss of $0.32 per fully diluted share, compared to a loss of $3,140,000, or a loss of $0.34 per fully diluted share, for the comparable period last year.

Consolidated net revenues from continuing operations for the six months ended December 31, 2012 decreased by 3.0% to $53,540,000 compared to $55,202,000 in the comparable period a year ago. The Healthcare Facilities Segment had net revenues in the six months ended December 31, 2012 of $37,551,000 compared to $36,775,000 for the comparable period a year ago. The Specialty Pharmacy Segment had $15,989,000 of net revenues for the six months ended December 31, 2012 compared to $18,427,000 last year.

SunLink had an operating loss from continuing operations for the six months ended December 31, 2012 of $3,465,000 compared to an operating loss of $2,568,000 for the six months ended December 31, 2011. Adjusted EBITDA for SunLink's Healthcare Facilities Segment was $1,046,000 in the six months ended December 31, 2012, compared to $1,637,000 for the comparable period last year. Adjusted EBITDA for the six months ended December 31, 2012 for the Specialty Pharmacy Segment was $204,000 compared to $239,000 for the comparable period last year.

SunLink Health Systems, Inc. is the parent company of subsidiaries that operate hospitals and related businesses in the Southeast and Midwest, and a specialty pharmacy company in Louisiana. Each hospital is the only hospital in its community and is operated locally with a strategy of linking patients' needs with dedicated physicians and healthcare professionals to deliver quality efficient medical care. For additional information on SunLink Health Systems, Inc., please visit the company's website at www.sunlinkhealth.com.

This press release may contain certain statements of a forward-looking nature. The statements contained herein which are not historical facts are considered forward-looking statements under federal securities laws. Such forward-looking statements are based on the beliefs of our management as well as assumptions made by and information currently available to them. The Company has no obligation to update such forward-looking statements. Actual results may vary significantly from these forward-looking statements.

Adjusted earnings before income taxes, interest, depreciation and amortization

Earnings before income taxes, interest, depreciation and amortization ("EBITDA") represent the sum of income before income taxes, interest, depreciation and amortization. We understand that certain industry analysts and investors generally consider EBITDA to be one measure of the liquidity of the company, and it is presented to assist analysts and investors in analyzing the ability of the company to generate cash, service debt and meet capital requirements. We believe increased EBITDA is an indicator of improved ability to service existing debt and to satisfy capital requirements. EBITDA, however, is not a measure of financial performance under accounting principles generally accepted in the United States of America and should not be considered an alternative to net income as a measure of operating performance or to cash liquidity. Because EBITDA is not a measure determined in accordance with accounting principles generally accepted in the United States of America and is thus susceptible to varying calculations, EBITDA, as presented, may not be comparable to other similarly titled measures of other corporations. Net cash provided by (used in) operations for the three and six months ended December 31, 2012 and 2011, respectively, is shown below. Healthcare Facilities Adjusted EBITDA and Specialty Pharmacy Adjusted EBITDA is the EBITDA for those facilities without any allocation of corporate overhead, impairment charges and gains on sale of businesses.

    Three Months Ended     Six Months Ended
December 31, December 31,
2012   2011 2012   2011
 

Healthcare Facilities Adjusted EBITDA

$ 934,000 $ 902,000 $ 1,046,000 $ 1,637,000
Specialty Pharmacy Adjusted EBITDA 124,000 285,000 204,000 239,000
Corporate overhead costs (1,043,000 ) (1,126,000 ) (1,953,000 ) (2,225,000 )
Taxes and interest expense (3,648,000 ) (626,000 ) (4,150,000 ) (981,000 )
Other non-cash expenses and net change in
operating assets and liabilities   5,495,000     889,000     4,973,000     307,000  
Net cash provided by operations $ 1,862,000   $ 324,000   $ 120,000   $ (1,023,000 )
 
SUNLINK HEALTH SYSTEMS, INC. ANNOUNCES FISCAL
2013 SECOND QUARTER AND SIX MONTHS RESULTS
Amounts in 000's, except per share and volume amounts
                                 
CONSOLIDATED STATEMENTS OF EARNINGS
Three Months Ended December 31,     Six Months Ended December 31,
2012 2011 2012 2011
% of Net % of Net % of Net % of Net
Amount Revenues Amount Revenues Amount Revenues Amount Revenues
Operating revenues (net of contractual allowances) $ 30,385 109.1 % $ 31,401 108.2 % $ 59,557 111.2 % $ 60,957 110.4 %
Less provision for bad debts of Healthcare Facilities Segment   2,535     9.1 %   2,376   8.2 %   6,017   11.2 %   5,755   10.4 %
Net Revenues 27,850 100.0 % 29,025 100.0 % 53,540 192.2 % 55,202 190.2 %
Costs and Expenses:
Cost of goods sold 6,529 23.4 % 7,807 26.9 % 10,766 20.1 % 12,741 23.1 %
Salaries, wages and benefits 13,386 48.1 % 13,219 45.5 % 26,607 49.7 % 26,352 47.7 %
Provision for bad debts of Specialty Pharmacy Segment 177 0.6 % 39 0.1 % 257 0.5 % 309 0.6 %
Supplies 2,437 8.8 % 2,069 7.1 % 4,700 8.8 % 4,260 7.7 %
Purchased services 1,896 6.8 % 1,858 6.4 % 3,852 7.2 % 3,923 7.1 %
Other operating expenses 3,976 14.3 % 4,035 13.9 % 8,081 15.1 % 8,111 14.7 %
Rents and leases 458 1.6 % 550 1.9 % 1,004 1.9 % 1,127 2.0 %
Impairments of property, plant and equipment - 0.0 % - 0.0 % 789 1.5 % - 0.0 %
Depreciation and amortization 989 3.6 % 1,120 3.9 % 1,973 3.7 % 2,219 4.0 %
Electronic Health Records incentives   (1,024 )   -3.7 %   (613 ) -2.1 %   (1,024 ) -1.9 %   (1,272 ) -2.3 %
Operating Loss (974 ) -3.5 % (1,059 ) -3.6 % (3,465 ) -6.5 % (2,568 ) -4.7 %
 
Interest Expense (647 ) -2.3 % (1,031 ) -3.6 % (1,206 ) -2.3 % (2,334 ) -4.2 %
Interest Income   -     0.0 %   -   0.0 %   -   0.0 %   2   0.0 %
 
Loss from Continuing Operations before
Income Taxes (1,621 ) -5.8 % (2,090 ) -7.2 % (4,671 ) -8.7 % (4,900 ) -8.9 %
Income Tax Benefit   (226 )   -0.8 %   (693 ) -2.4 %   (1,654 ) -3.1 %   (1,760 ) -3.2 %
Loss from Continuing Operations (1,395 ) -5.0 % (1,397 ) -4.8 % (3,017 ) -10.8 % (3,140 ) -10.8 %
Earnings from Discontinued Operations,
net of income taxes   5,330     19.1 %   462   1.6 %   5,528   10.3 %   650   1.2 %
Net Earnings (Loss) $ 3,935     14.1 % $ (935 ) -3.2 % $ 2,511   9.0 % $ (2,490 ) -8.6 %
Loss Per Share from Continuing Operations:
Basic $ (0.15 ) $ (0.15 ) $ (0.32

Increase your money and finance knowledge from home

Behavioral Finance

Why do investors make the decisions that they do?

View Course »

Reading a Stock Quote

Learn to read the ingredients of a stock.

View Course »

Add a Comment

*0 / 3000 Character Maximum